US 12043831
Modulation of alpha synuclein expression
granted A61PA61P21/00A61P25/00
Quick answer
US patent 12043831 (Modulation of alpha synuclein expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/02, A61P25/16